The "cross" signs in patients with multiple system atrophy: A quantitative study

Journal of Neuroimaging

Volumn 16, Issue 1, 2006, Pages 73-77

  Abe, Kazuo ^a,b   Hikita, Tachio ^a   Yokoe, Masaru ^a   Mihara, Masahito ^a   Sakoda, Saburo ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

MRI; Multiple system atrophy (MSA)

Indexed keywords

ADULT; AGED; ARTICLE; CEREBELLAR ATAXIA; CEREBELLUM VERMIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PONS; QUANTITATIVE ANALYSIS; SHY DRAGER SYNDROME;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY;

EID: 32544445985     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1177/1051228405279988     Document Type: Article

References (16)

1. Graham J, Oppenheimer D. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
2. Lowe J, Levvox G, Leigh N. Disorders of movement and system degenerations. In: Graham DI, Lantos PL, editors. Greenfield's Neuropathology. London: Arnold; 1997:281-366.
3. Bürk K, Skalej M, Dichgans J. Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA). Mov Disord 2001;16:535-536.
4. Horimoto Y, Aiba I, Yasuda T, et al. Longitudinal MRI study of multiple system atrophy-when do the findings appear, and what is the course? J Neurol 2002;249;847-854.
5. Kraft E, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002;59:1265-1267.
6. Kashmere J, Camicioli R, Martin W. Parkinsonian syndromes and differential diagnosis. Curr Opin Neurol 2002;15:461-466.
7. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
8. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004;3:93-103.
9. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997;145:205-211.
10. Abe K, Nishikawa Y, Fujimura H, et al. Clinical and magnetic resonance image correlation in idiopathic cerebellar ataxia. J Neurol Sci 1995;133:53-60.
11. Schott JM, Simon JE, Fox NC, et al. Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Mov Disord 2003;18:955-958.
12. Lo Coco D, Lunetta C, Piccoli F, et al. How specific are the pontine MRI hyperintensities (the cross sign)? Eur Neurol 2003;10:108-109.
13. Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65-71.
14. Naka H, Ohshita T, Murata Y, Imon Y, Mimori Y, Nakamura S. Characteristic MRI findings in multiple system atrophy: comparison of the three subtypes. Neuroradiology 2002;44:204-209.
15. Muqit MMK, Mort D, Miszkiel KA, et al. "Hot cross bun" sign in a patient with parkinsonism secondary to presumed vasculitis. J Neurol Neurosurg Psychiatry 2001;71:565-566.
16. Murata Y, Yamaguchi S, Kawakami H, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol 1998;55:33-37.